News & Analysis on Clinical Trial Services & Contract Research And Development
HumanFirst: OpenAtlas sensor evaluation tool
By Jenni Spinner
- Last updated on
HumanFirst has launched OpenAtlas, a no-cost tier of its Atlas platform that enables users to check out and compare more than 1,200 wearables, sensors, and software-based evaluation tools. The company worked with experts from the Digital Medicine (DiMe) Society, US Food and Drug Administration, and others to help create The Digital Measures Playbook, an open-access framework for decreasing risk when deploying, managing, and monitoring connected products in the home.
“Catalyzed by the COVID-19 pandemic, the biopharmaceutical industry has continued to shift clinical trials to home and hybrid models in order to increase access, speed up studies, and provide more patient-centric information,” said Andrea Coravos, CEO and co-founder of HumanFirst. “As clinical trial study teams look to adopt connected health technologies for decentralized trials, our platform helps them evaluate the overwhelming number of products on the market and design a way to safely, effectively, and equitably deploy them.”